BCL6 and B-cell non-Hodgkin lymphoma: BCL6 is also expressed in a subgroup of T-cell lymphoma, angioimmunoblastic T-cell lymphoma, derived from CD4+ T-cell subset follicular helper (Tfh) cells (10), as well as other B-cell lymphomas (follicular lymphoma (11) and Burkitt lymphoma) and other malignancies including breast cancer (12, 13) and non-small cell lung cancer (14) and could potentially be a therapeutic target in these conditions.